About
Rouxjeane Venter, PhD, is a molecular biologist and clinical researcher in the Division of Molecular Biology and Human Genetics at Stellenbosch University. Her research focuses on tuberculosis (TB) infectiousness, transmission, and diagnostic innovation, with particular emphasis on aerosol sampling and non-sputum–based diagnostic approaches.
She leads and collaborates on clinical and translational studies evaluating bioaerosol capture technologies, molecular detection platforms, and strategies to improve drug-resistance testing. Her work integrates laboratory science with field-based implementation research in high TB burden settings, aiming to improve early case detection and reduce onward transmission.
In addition to aerosol research, she contributes to diagnostic development initiatives, including genomic material recovery from GeneXpert cartridges for downstream sequencing and resistance profiling. Her research is grounded in translational impact, bridging molecular microbiology, clinical epidemiology, and health system implementation to strengthen TB control efforts in high-burden regions.
Employment
-
Stellenbosch University Researcher2026 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (27)
- Oral Washes and Tongue Swabs for Xpert MTB/RIF Ultra–Based Tuberculosis Diagnosis in People With and Without the Ability to Make Sputum Save
- EXTRACTION DEVICE ASSEMBLY Save
- Preferences for tongue swab versus sputum collection for TB testing: a multi-country survey Save
- Priorities in addressing rifampicin resistant TB. Save
- Detection of Aerosolized Mycobacterium tuberculosis DNA From Adults Being Investigated for Pulmonary Tuberculosis via an Electrostatic Sampler in a South African Primary Care Setting Save
- AveloMask, a novel breath aerosol collection kit for airborne Mycobacterium tuberculosis: a proof-of-principle assessment. Save
- Diagnostic Accuracy of LiquidArray MTB-XDR VER 1.0 for the Detection of Mycobacterium tuberculosis Complex, Fluoroquinolone, Amikacin, Ethambutol, and Linezolid Susceptibility Save
- Informing People-Centered Target Product Profiles for TB Diagnostics: A Multi-Country Qualitative Study Save
- Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis. Save
- Xpert MTB/RIF Ultra-resistant and MTBDRplus-susceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing. Save